According to the Lekai Film announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for three consecutive trading days from January 6 to 8, 2026, which was an abnormal fluctuation. After self-inspection and inquiries with controlling shareholders, as of the date of disclosure of the announcement, the company, controlling shareholders and actual controllers were not required to disclose important matters, the main business had not changed, production and operation were normal, and there were no hot conceptual matters. In the first three quarters of 2025, the company had revenue of 960 million yuan and net profit - 86 million yuan. Annual results may still be lost, reminding investors to pay attention to transaction risks.

According to the Lekai Film announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for three consecutive trading days from January 6 to 8, 2026, which was an abnormal fluctuation. After self-inspection and inquiries with controlling shareholders, as of the date of disclosure of the announcement, the company, controlling shareholders and actual controllers were not required to disclose important matters, the main business had not changed, production and operation were normal, and there were no hot conceptual matters. In the first three quarters of 2025, the company had revenue of 960 million yuan and net profit - 86 million yuan. Annual results may still be lost, reminding investors to pay attention to transaction risks.